Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine Single-Shot vs Continuous ESPB for PCNL Pain
NCT04650737Unknown
- Sponsor
- Cairo University
- Start
- Dec 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
Randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Cairo University. Primary endpoint: Duration of postoperative Analgesia at 24 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04650737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04650737.